Zonova is a UK-based antimicrobial materials company developing embedded antimicrobial technologies for medical devices. Founded in 2023, the company’s proprietary platform integrates antimicrobial protection directly into polymers to prevent microbial colonisation and biofilm formation without relying on antibiotics or toxic leaching compounds. Zonova partners with medical device manufacturers through a scalable licensing model designed to accelerate infection-resistant innovation across global healthcare systems.
Zonova: Venture Capital Funding History
Zonova
Zonova
- Health
- London, United Kingdom
- £2.1m
- zonovatech.com
- Update Information
More venture news
- 14 Oct 2026

StrideStride raises a £4.6m seed round led by Arāya Ventures to offer diagnostics-driven preventative health memberships
SeedHealth - 13 Oct 2026

Log my CareLog my Care secures £2m in venture debt from Palatine Growth Credit to provide the care sector with digital management software
Venture debtHealth - 12 Oct 2026

ScarletScarlet unlocks a £40m Series B led by Headline for AI-native certification of medical software and devices
Series BHealth
